What is the current stock price of MabCure, Inc. (MBCI)?

As of the latest market data, MabCure, Inc. (MBCI) is trading at $0.00. The stock has seen a loss of 0.00% today.

Does MabCure, Inc. (MBCI) pay a dividend?

Based on current data, MabCure, Inc. does not have a confirmed active dividend policy.

What is the market cap of MabCure, Inc.?

The current market capitalization of MabCure, Inc. (MBCI) is approximately unavailable.

MBCI

MabCure, Inc.·Energy

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.00

Company Profile

MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.

Sector

Energy

Industry

Solar

Employees

IPO Date

2007-12-05

Beta

9.86

Websitewww.mabcure.com↗